Gastrointestinal Cancer
2 competing products in clinical development for Gastrointestinal Cancer.
Pipeline by Phase
Phase 1/21
Phase 21
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Raludotatug Deruxtecan (R-DXd) | Daiichi Sankyo | Phase 2 | Active | 39 |
| Patritumab deruxtecan | Daiichi Sankyo | Phase 1/2 | Recruiting | 39 |